Abstract:The World Health Organization Classification of Tumors of the Central Nervous System (WHO CNS5) significantly revised the terminology and diagnostic criteria of "mesenchymal non-meningothelial" tumors of CNS to better align with the classification of these soft tissue tumors outside the CNS. The CNS chapter only covers the entities with distinct histological or molecular characteristics that occur exclusively or primarily in the CNS. These tumors usually arise from the meninges and are rarely intraparenchymal in origin, mainly in the supratentorial compartment. These tumors are grouped into three main categories: soft tissue, chondro-osseous, and notochordal. Soft tissue tumors, the largest group, are further divided into fibroblastic, vascular, and skeletal muscle subtypes. Notably, a new subcategory for "tumors of uncertain differentiation" has been introduced, encompassing three new histomolecular entities: FET::CREB fusion-positive, CIC-rearranged sarcoma, and primary intracranial sarcoma, DICER1-mutant. Emerging entities like dural angioleiomyomas and spindle cell neoplasms with NTRK-rearrangements have been reviewed, although not introduced in WHO CNS5. Given the often non-specific histology and immunophenotype of mesenchymal nonmeningothelial tumors of uncertain differentiation, molecular techniques have become indispensable for accurate diagnosis. This review provides a comprehensive overview of primary mesenchymal non-meningothelial CNS tumors, including their clinical, radiological, histopathological, and molecular characteristics and treatment strategies.ABBREVIATIONS: ALK: Anaplastic lymphoma kinase; ATF1: activating transcriptase factor-1; CREB: cAMP response element-binding protein; CREM: cAMP response element modulator; CIC: Capicua transcriptional receptor; EWSR1: Ewing sarcoma RNA binding protein; FUS: fused in sarcoma; NAB2: nerve growth factor-inducible protein A binding protein 2; STAT6: signal transducer and activator of transcription 6; WHO: World Health Organization WHO CNS5: World Health Organization Classification of Tumors of the Central Nervous System, fifth edition.

Quasidiatomic study of Ly- alpha -producing H2 +-Ne collisions at keV energies.

Mesenchymal Non-Meningothelial Tumors of the CNS: Evolving Molecular Landscape and Implications for Neuroradiologists

An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB‐fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts

Central nervous system solitary fibrous tumors: Case series in accordance with the WHO 2021 reclassification. Framework for patient surveillance

Solitary fibrous tumor of the brain: A report of 3 cases

Solitary fibrous tumors: 3 case reports and literature review

The 2007 WHO Classification of Tumours of the Central Nervous System

Intracranial solitary fibrous tumors: Clinical, radiological, and histopathological insights along with review of literature

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

Electroactive planar waveguide studies of Ru(bpy)3(2+) intercalated in a thin clay film: I. Transport and electrochemical phenomena.

[Innovations in the classification of soft tissue tumors]

Advances in the molecular biology of the solitary fibrous tumor and potential impact on clinical applications

Solitary Fibrous Tumor of the Central Nervous System: a Clinicopathologic Study of 24 Cases

[The effect of circulatory insufficiency on amino acid metabolism in the cerebral cortex of animals].

Path-01. Sellar Solitary Fibrous Tumors Who Grade Ii And Iii: Mimics Of Non-Functioning Pituitary Adenomas

Embryonal brain tumor with unknown primary lesion and massive cerebrospinal fluid dissemination: A case report

Cutaneous soft tissue tumors: how do we make sense of fibrous and "fibrohistiocytic" tumors with confusing names and similar appearances?

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors

Solitary Fibrous Tumour Extending Both Extracranially and Intracranially.

The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis

Spinal Intramedullary Solitary Fibrous Tumor: A Rare and Challenging Diagnosis